Yong Xu Selected Research

myocardin

1/2022	Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice.
1/2020	An MRTF-A-Sp1-PDE5 Axis Mediates Angiotensin-II-Induced Cardiomyocyte Hypertrophy.
10/2018	Myocardin-related transcription factor A (MRTF-A) mediates doxorubicin-induced PERP transcription in colon cancer cells.
10/2018	Myocardin-related transcription factor A (MRTF-A) contributes to acute kidney injury by regulating macrophage ROS production.
2/2016	Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling.
7/2015	Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy.
4/2015	Megakaryocytic leukemia 1 directs a histone H3 lysine 4 methyltransferase complex to regulate hypoxic pulmonary hypertension.
3/2015	Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Xu Research Topics

Disease

240	Neoplasms (Cancer) 10/2022 - 05/2002
83	Prostatic Neoplasms (Prostate Cancer) 08/2022 - 05/2002
64	Inflammation (Inflammations) 06/2022 - 07/2003
60	Obesity 03/2022 - 11/2008
49	Body Weight (Weight, Body) 01/2022 - 10/2006
48	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2002
44	Schizophrenia (Dementia Praecox) 10/2022 - 08/2008
33	Insulin Resistance 08/2022 - 11/2009
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 10/2006
31	Carcinogenesis 01/2022 - 09/2007
31	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2011
31	Fibrosis (Cirrhosis) 01/2021 - 04/2003
26	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2013
25	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 04/2002
20	Hypoxia (Hypoxemia) 01/2021 - 08/2009
20	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 10/2006
19	Infections 01/2022 - 01/2002
18	Carcinoma (Carcinomatosis) 01/2022 - 03/2004
17	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2014
17	Cognitive Dysfunction 01/2022 - 03/2014
16	Hypertension (High Blood Pressure) 01/2022 - 06/2005
16	Hallucinations (Hallucination) 01/2022 - 01/2019
15	Lung Neoplasms (Lung Cancer) 08/2022 - 09/2008
13	Atherosclerosis 01/2022 - 05/2009
13	Reperfusion Injury 01/2022 - 01/2013
13	Ischemia 01/2021 - 01/2012
12	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 11/2005
12	Lymphatic Metastasis 01/2022 - 05/2012
12	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 05/2008
12	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2017 - 03/2003
11	Weight Gain 10/2022 - 01/2012
11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2003
11	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2013
10	Cardiomegaly (Heart Hypertrophy) 01/2022 - 03/2015
10	Hyperglycemia 11/2021 - 12/2013
10	Stomach Neoplasms (Stomach Cancer) 01/2020 - 08/2013
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 01/2014
9	Nasopharyngeal Carcinoma 08/2022 - 05/2002
9	Adenocarcinoma of Lung 01/2022 - 08/2009
9	Stroke (Strokes) 01/2022 - 02/2013
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 05/2012
9	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2011
9	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2017
9	Peripheral Nervous System Diseases (PNS Diseases) 09/2021 - 01/2016
9	Weight Loss (Weight Reduction) 01/2021 - 12/2006
8	Hyperphagia (Overeating) 01/2022 - 11/2008

Drug/Important Bio-Agent (IBA)

87	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2008
60	Biomarkers (Surrogate Marker)IBA 08/2022 - 12/2005
52	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 04/2002
50	Pharmaceutical PreparationsIBA 08/2022 - 07/2011
30	Biological ProductsIBA 04/2022 - 07/2003
29	CytokinesIBA 01/2022 - 11/2005
26	MicroRNAs (MicroRNA)IBA 06/2022 - 06/2010
23	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2004
22	Messenger RNA (mRNA)IBA 03/2022 - 03/2003
21	Small Interfering RNA (siRNA)IBA 01/2020 - 10/2006
20	Antipsychotic Agents (Antipsychotics)IBA 10/2022 - 03/2015
20	LipidsIBA 03/2022 - 10/2003
19	Long Noncoding RNAIBA 08/2022 - 01/2014
18	EnzymesIBA 01/2020 - 08/2004
17	Estrogens (Estrogen)FDA Link 01/2022 - 11/2003
17	Therapeutic UsesIBA 06/2021 - 07/2007
17	Sirtuin 1IBA 10/2019 - 12/2011
16	AntioxidantsIBA 08/2022 - 01/2006
16	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2021 - 11/2009
16	Phosphotransferases (Kinase)IBA 02/2021 - 04/2010
16	Prostate-Specific Antigen (Semenogelase)IBA 09/2019 - 04/2010
14	CollagenIBA 07/2022 - 12/2003
14	RNA (Ribonucleic Acid)IBA 03/2022 - 02/2008
14	LeptinIBA 11/2021 - 04/2010
14	LigandsIBA 10/2021 - 02/2004
14	Histones (Histone)IBA 09/2020 - 07/2009
12	Insulin (Novolin)FDA Link 08/2022 - 06/2005
12	oxidized low density lipoproteinIBA 08/2022 - 03/2004
11	CholesterolIBA 08/2022 - 11/2003
11	AntigensIBA 11/2019 - 05/2007
10	CreatinineIBA 12/2021 - 06/2016
10	Blood Glucose (Blood Sugar)IBA 12/2021 - 12/2015
10	Scavenger Receptors (Scavenger Receptor)IBA 01/2021 - 03/2004
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2010
10	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2016
9	HMGB1 Protein (HMG1)IBA 11/2022 - 01/2012
9	Triglycerides (Triacylglycerol)IBA 08/2022 - 06/2005
9	Serotonin (5 Hydroxytryptamine)IBA 07/2022 - 11/2008
9	IronIBA 06/2022 - 11/2014
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2011
9	CateninsIBA 01/2022 - 06/2014
9	InflammasomesIBA 01/2021 - 01/2016
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 12/2002
8	PlatinumIBA 06/2022 - 06/2016
8	myocardinIBA 01/2022 - 03/2015
8	NAD (NADH)IBA 09/2021 - 01/2016
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2014
8	Angiotensin IIIBA 01/2021 - 08/2014

Therapy/Procedure

110	Therapeutics 10/2022 - 02/2003
32	Drug Therapy (Chemotherapy) 10/2022 - 10/2006
31	Radiotherapy 04/2022 - 10/2006
12	Immunotherapy 01/2022 - 09/2003
11	Castration 11/2019 - 03/2003
9	Operative Time 04/2020 - 07/2007